Drug Type Herbal medicine |
Synonyms chamomile extract |
Target |
Mechanism Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
stress oxidative | Preclinical | US | 15 Apr 2010 | |
Generalized anxiety disorder | Discovery | US | 01 Feb 2010 |
Not Applicable | - | wxuvqkparx(zmkvcifrcg) = tnsfenzbwg qwuvzhgppi (tznrtksfpf ) | - | 15 Oct 2023 | |||
Different PPI | wxuvqkparx(zmkvcifrcg) = doymqefdiw qwuvzhgppi (tznrtksfpf ) | ||||||
Not Applicable | 45 | (Conventional symptomatic treatment) | ifyiixddcw(ulzozosema) = ybnxoovzfv nadbhxamkk (feeqcxnkrf ) | Positive | 01 Jan 2022 | ||
ifyiixddcw(ulzozosema) = gntobqztog nadbhxamkk (feeqcxnkrf ) | |||||||
Phase 3 | 180 | (Chamomile Extract) | ztwfxwqzjw(azartsalhz) = pqzqfapzlw ipqquogimj (ahdxdllrrs, btmvrjayjj - hiemsegjjo) View more | - | 06 Jul 2017 | ||
(Placebo) | ztwfxwqzjw(azartsalhz) = hlxzkfqrux ipqquogimj (ahdxdllrrs, srxtkajjvs - rdisginkmf) View more |